Thyrotoxic periodic paralysis after urethral dilatation

Thyrotoxic periodic paralysis (TPP) is a rare and serious manifestation of thyrotoxicosis that causes flaccid paralysis. In severe cases, it can be life-threatening due to respiratory failure and cardiac arrhythmias. TPP is due to increased sodium/potassium ATPase activity during thyrotoxic states,...

Full description

Bibliographic Details
Main Authors: Moayyad Alziadat, Mourad Ismail
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2020-10-01
Series:Avicenna Journal of Medicine
Subjects:
Online Access:http://www.thieme-connect.de/DOI/DOI?10.4103/ajm.ajm_54_20
id doaj-ebc8af4841be41b4ad8f530dc36dec33
record_format Article
spelling doaj-ebc8af4841be41b4ad8f530dc36dec332021-08-04T22:41:59ZengWolters Kluwer Medknow PublicationsAvicenna Journal of Medicine2231-07702249-44642020-10-01100424925110.4103/ajm.ajm_54_20Thyrotoxic periodic paralysis after urethral dilatationMoayyad Alziadat0Mourad Ismail1Department of Critical Care Medicine, St Joseph’s University Medical Center, Paterson, New Jersey, USADepartment of Critical Care Medicine, St Joseph’s University Medical Center, Paterson, New Jersey, USAThyrotoxic periodic paralysis (TPP) is a rare and serious manifestation of thyrotoxicosis that causes flaccid paralysis. In severe cases, it can be life-threatening due to respiratory failure and cardiac arrhythmias. TPP is due to increased sodium/potassium ATPase activity during thyrotoxic states, which is due to mutations encoding potassium channels. It is precipitated by situations that cause a surge in catecholamines, insulin, or both. It can be treated with potassium supplementation and nonselective beta blockers, and it can be prevented by establishing euthyroid state. With the increasing numbers of outpatient procedures performed nowadays and the stress related to these procedures, patients with TPP may develop paralysis after these procedures, so clinicians should be aware of this condition and the importance of identifying it in patients presenting with flaccid paralysis.http://www.thieme-connect.de/DOI/DOI?10.4103/ajm.ajm_54_20hypokalemiaparalysisperiodicthyrotoxicthyrotoxicosis
collection DOAJ
language English
format Article
sources DOAJ
author Moayyad Alziadat
Mourad Ismail
spellingShingle Moayyad Alziadat
Mourad Ismail
Thyrotoxic periodic paralysis after urethral dilatation
Avicenna Journal of Medicine
hypokalemia
paralysis
periodic
thyrotoxic
thyrotoxicosis
author_facet Moayyad Alziadat
Mourad Ismail
author_sort Moayyad Alziadat
title Thyrotoxic periodic paralysis after urethral dilatation
title_short Thyrotoxic periodic paralysis after urethral dilatation
title_full Thyrotoxic periodic paralysis after urethral dilatation
title_fullStr Thyrotoxic periodic paralysis after urethral dilatation
title_full_unstemmed Thyrotoxic periodic paralysis after urethral dilatation
title_sort thyrotoxic periodic paralysis after urethral dilatation
publisher Wolters Kluwer Medknow Publications
series Avicenna Journal of Medicine
issn 2231-0770
2249-4464
publishDate 2020-10-01
description Thyrotoxic periodic paralysis (TPP) is a rare and serious manifestation of thyrotoxicosis that causes flaccid paralysis. In severe cases, it can be life-threatening due to respiratory failure and cardiac arrhythmias. TPP is due to increased sodium/potassium ATPase activity during thyrotoxic states, which is due to mutations encoding potassium channels. It is precipitated by situations that cause a surge in catecholamines, insulin, or both. It can be treated with potassium supplementation and nonselective beta blockers, and it can be prevented by establishing euthyroid state. With the increasing numbers of outpatient procedures performed nowadays and the stress related to these procedures, patients with TPP may develop paralysis after these procedures, so clinicians should be aware of this condition and the importance of identifying it in patients presenting with flaccid paralysis.
topic hypokalemia
paralysis
periodic
thyrotoxic
thyrotoxicosis
url http://www.thieme-connect.de/DOI/DOI?10.4103/ajm.ajm_54_20
work_keys_str_mv AT moayyadalziadat thyrotoxicperiodicparalysisafterurethraldilatation
AT mouradismail thyrotoxicperiodicparalysisafterurethraldilatation
_version_ 1721221729382039552